RETRACTED: Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease

Alzheimer’s disease (AD) is a severe neurodegenerative disorder of the brain that manifests as dementia, disorientation, difficulty in speech, and progressive cognitive and behavioral impairment. The emerging therapeutic approach to AD management is the inhibition of β-site APP cleaving enzyme-1 (BA...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nobendu Mukerjee, Anubhab Das, Rahul D. Jawarkar, Swastika Maitra, Padmashree Das, Melvin A. Castrosanto, Soumyadip Paul, Abdul Samad, Magdi E. A. Zaki, Sami A. Al-Hussain, Vijay H. Masand, Mohammad Mehedi Hasan, Syed Nasir Abbas Bukhari, Asma Perveen, Badrah S. Alghamdi, Athanasios Alexiou, Mohammad Amjad Kamal, Abhijit Dey, Sumira Malik, Ravindra L. Bakal, Adel Mohammad Abuzenadah, Arabinda Ghosh, Ghulam Md Ashraf
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
coleção:	Frontiers in Aging Neuroscience
Assuntos:	beta-site APP cleaving enzyme 1 BACE1 Alzheimer’s disease glioblastoma QSAR molecular docking
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.878276/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!